RTX-006

N/A

Report date: 2023/01/07 20:44:14

Base Information

Drug NameRTX-006
Drug Alias NameRTX-006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsAutoimmune Diseases of the Nervous SystemNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRubryc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRubryc Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases of the Nervous SystemNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A